169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
TEM-1 diagnostic antibodies
#3302Humanized or affinity-matured anti Ang-2 antibody and uses thereof
#3303Type 2 diabetes biomarkers and uses thereof
#3304Chemical model of a neurodegenerative disease, method for preparation and uses of same
#3305Analysis of a panel of cerebrotendinous xanthomatosis biomarkers using site specific derivation and LC/MS/MS workflow
#3306Methods for the prevention or treatment of scoliosis
#3307Methods and devices for rapid assessment of severity of injury
#3308Biomarkers for liver fibrosis
#3309METHOD FOR THE DIAGNOSIS OF SYSTEMIC SCLERODERMA OR OF PULMONARY ARTERIAL HYPERTENSION
#3310Biomarkers in inflammatory bowel disease
#3311Immunochromatography devices, methods, and kits
#3312Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#3313Diagnostic markers for platelet function and methods of use
#3314Saposin-A derived peptides and uses thereof
#3315Method for the diagnosis of metachromatic leukodystrophy
#3316CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
#3317Prion epitopes and methods of use thereof
#3318ACUTE KIDNEY INJURY
#3319Isovalerylglycine as biomarker for the predispositon for weight gain and obesity
#3320Diagnostic and therapeutic methods and products related to anxiety disorders
#3321Synthetic ligands for the differentiation of closely related toxins and pathogens
#3322Methods for diagnosing and treating inflammatory bowel disease
#3323Hemoglobin receptor as novel vaccine for leishmaniasis
#3324Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#3325Lipid biomarkers for stable and unstable heart disease
#3326METHODS AND ASSAYS FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#3327Biomarkers for the identification of liver damage
#3328Methods for determining the risk of acute graft versus host disease
#3329Polypeptides and polypeptide constructs comprising single domain antibodies directed against von Willebrand factor
#3330METHODS OF TREATING PULMONARY FIBROSIS
#3331METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#3332Method to determine treatment of acute heart failure
#3333Cathelicidin as novel inflammatory bowel disease marker and therapy for colitis associated intestinal fibrosis
#3334USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE
#3335Method for testing for cardiovascular disease with cyclophilin A
#3336MARKER SEQUENCES FOR RHEUMATOID ARTHRITIS
#3337ASSESSING RENAL STRUCTURAL ALTERATIONS AND OUTCOMES
#3338Signal amplification in lateral flow and related immunoassays
#3339Sortilin 1 is a novel inducer of vascular calcification
#3340Pharmaceutical composition for use in the treatment of dysfunction associated with aging
#3341Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#3342COMPOSITIONS AND METHODS RELATED TO DORMANT SENESCENCE-PRONE CELLS (DSPC)
#3343Therapeutic and diagnostic methods and compositions for neurodegenerative diseases
#3344Marker peptide for determining risk of hyperglycemia and use thereof
#3345Non-invasive biomarker to identify subject at risk of preterm delivery
#3346METHOD FOR IDENTIFYING MOLECULAR MARKERS OF CHILDREN'S SKIN
#3347Methods and Devices for Detecting Diabetic Nephropathy and Associated Disorders
#3348DETERMINING DISEASE STATES USING BIOMARKER PROFILES
#3349BIOMARKERS FOR THE PROGNOSIS OF ISCHEMIC STROKE
#3350Collagen-derived recombinant proteins with von Willebrand factor-binding activity
#3351Therapeutic or prophylactic agent for retinopathy of prematurity, testing method for retinopathy of prematurity, and screening method for therapeutic or prophylactic substance for retinopathy of prematurity
#3352Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
#3353Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
#3354Methods for the diagnosis and treatment of sjögren's syndrome
#3355Markers for preeclampsia
#3356BIOMARKERS IN THE SELECTION OF THERAPY OF HEART FAILURE
#3357Method for testing for nephritis-lesion sites and reagent therefor
#3358Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction
#3359PROSTATITIS-ASSOCIATED ANTIGENS AND METHODS OF USE THEREOF
#3360SCHIZOPHRENIA MARKER SET AND ITS UTILIZATION
#3361Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation
#3362Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm
#3363Methods of using genetic variants for the diagnosis and treatment of inflammatory bowel disease
#3364PROCESSES AND KITS TO DETECT AND MONITOR FOR DIAGNOSTIC BIOMARKERS FOR POST TRAUMATIC STRESS DISORDER (PTSD) AND TO DIFFERENTIATE BETWEEN SUICIDAL AND NON-SUICIDAL FORM OF THE DISORDER
#3365Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
#3366Method of inhibiting or treating cancer metastasis
#3367Method of treating sepsis by administering a soluble CD52 glycoprotein
#3368Diagnostic marker for treatment of cerebral ischemia
#3369Nanocarriers and their processing for diagnostics and therapeutics
#3370Detecting infection in reduced pressure wound treatment
#3371Method of cancer diagnosis, progression and response to therapy using a primary xenograft mouse model for cancer serum biomarker discovery
#3372TREATMENT OF AUTOPHAGY-BASED DISORDERS AND RELATED PHARMACEUTICAL COMPOSITIONS, DIAGNOSTIC AND SCREENING ASSAYS AND KITS
#3373MARKER ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS
#3374Methods and kits for predicting a response to an erythropoietic agent
#3375Use of GFAP for identification of intracerebral hemorrhage
#3376Diagnostic method for detecting an autoimmune disease
#3377Porcine parvovirus 5A, methods of use and vaccine
#3378Methods and compositions for detecting endometrial or ovarian cancer
#3379Method for diagnosing muscular dystrophy
#3380NT-proCNP as a biomarker of vascular disorders and pregnancy complication
#3381Molecularly imprinted polymer for detection of pentraxin protein and method for preparing the same
#3382Methods for detecting heparin/platelet factor 4 antibodies
#3383Anti-presepsin antibody
#3384Body Fluid BIN1 as a Marker of Cardiac Health
#3385TnT BASED DIAGNOSIS OF PAROXYSMAL ATRIAL FIBRILLATION
#3386Use of interleukin-27 as a diagnostic biomarker for bacterial infection in critically ill patients
#3387Methods and compositions for biomarkers of fatigue
#3388ANKRD26 AS A MARKER FOR DIAGNOSIS OF THROMBOCYTOPENIAS
#3389Methods for Diagnosing Mood Disorders
#3390Method for measuring the level of circulating inhibitory factor 1 protein in a subject measuring the level of circulating inhibitory factor 1 (IF1) protein in a subject
#3391COMPLEX COMPRSING BEAD PARTICLE INCLUDING QUANTUM DOT LAYER AND METHOD OF DIAGNOSING MYOCARDIAL INFARCTION-RELATED DISEASE BY USING THE COMPLEX
#3392Immunoassay kit for quantification of BNP and proBNP
#3393Biomarkers for non-alcoholic fatty liver disease, and methods for detecting non-alcoholic fatty liver disease by using such biomarkers
#3394Method for detection of IGFBP-4 fragments
#3395Kidney disease biomarker
#3396Diagnostic of Heart Failure
#3397Integrated quantification method for protein measurements in clinical proteomics
#3398Methods and compositions for diagnosis of inflammatory liver disease
#3399Assay
#3400Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#3401Compositions and methods for diagnosing and treating an inflammation
#3402Semaphorin 3A for treatment and assessment of severity of Asthma
#3403Treatment of circadian rhythm disorders
#3404Monoclonal IgE antibody that binds to sweat allergy antigen protein
#3405Methods and compounds for reducing threonyl-tRNA synthetase activity
#3406Compositions and methods for detecting, treating and preventing diseases and disorders
#3407Beta klotho binding proteins and methods of use thereof
#3408Human islet amyloid polypeptide (hIAPP) specific antibodies and uses thereof
#3409METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES
#3410Method for providing reliable non-invasive diagnostic tests
#3411Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#3412Human myeloid derived suppressor cell cancer markers
#3413Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients
#3414Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#3415Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases
#3416Use of anoctamin as a biomarker for radiation biodosimetry
#3417Biomarkers for type 2 diabetes
#3418Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#3419PLASMA ANALYTES PREDICT DIAGNOSIS AND PROGNOSIS OF THORACIC AORTIC ANEURYSM
#3420Screening methods for transfusion related acute lung injury (TRALI)
#3421Blood biomarker for early blood brain barrier disruption in ischemic stroke
#3422METHODS OF DIAGNOSING AND DETERMINING RISK OF DEVELOPING DISSEMINATED INTRAVASCULAR COAGULATION
#3423Soluble MANF in pancreatic β-cell disorders
#3424Angiopoietin-like 4 and a method of its use in wound healing
#3425BIOMARKERS FOR DIAGNOSING AND/OR MONITORING TUBERCULOSIS
#3426Detection method of mammary gland disease
#3427Oxidative biomarkers in predicting risk of stroke, transient ischemic attack (TIA) and peripheral arterial disease (PAD)
#3428METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#3429Susceptibility to and stratification for monoaminergic antidepressants
#3430METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF SEPSIS
#3431Methods for treatment of cardiovascular disease
#3432PARALLEL ANALYSIS OF SERUM EPCAM AND MMP7 TO DISCRIMINATE SEPSIS, NECROTIZING ENTEROCOLITIS AND NORMAL CONTROL PATIENTS
#3433Device and associated methods for performing luminescence and fluorescence measurements of a sample
#3434Device and associated methods for performing luminescence and fluorescence measurements of a sample
#3435RAC1 inhibitors for the treatment of alport glomerular disease
#3436Composition for preventing or treating fracture or osteoporosis using slit-robo system
#3437TRIAGE SCORING SYSTEM
#3438Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals
#3439Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension
#3440ANTI-PRO87299 ANTIBODIES
#3441GAMMA-AMINOBUTYRIC ACID A RECEPTOR SUBUNIT BIOMARKERS
#3442Host Biomarkers for Dengue Fever (DF) and Methods Thereof
#3443Marker peptide for determining risk of developing metabolic syndrome, and use thereof
#3444Means and methods for diagnosing and monitoring heart failure in a subject
#3445Methods of predicting and decreasing the risk of pre-term birth
#3446Methods to identify modulators of RyR calcium channels
#3447MARKERS OF THE MALE UROGENITAL TRACT
#3448METHODS FOR DIAGNOSING OSTEOARTHRITIS
#3449Status of Tuberculosis Infection in an Individual
#34501L1RL-1 as a cardiovascular disease marker and therapeutic target
#3451Metabolomics in pneumonia and sepsis
#3452Methods and devices for tuberculosis diagnosis using biomarker profiles
#3453BAG3 as biochemical serum and tissue marker
#3454DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
#3455CARIES RISK TEST FOR PREDICTING AND ASSESSING THE RISK OF DISEASE
#3456Cardiovascular disease primary prevention agent for patients having high blood levels of high-sensitivity C-reactive protein
#3457Methods useful for vitamin D deficiency and related disorders
#3458Methods and compositions for the treatment of β-thalassemia
#3459Therapeutic agent, treatment method and inspection method for diseases caused by activation of neutrophils
#3460Method for diagnosing acute alcoholic hepatitis
#3461METHODS FOR DETECTING AMYLOID BETA AMYLOIDOSIS
#3462Anti-αβantibodies
#3463Compositions and methods for identifying and diagnosing salt sensitivity of blood pressure
#3464Method for predicting risk of exposure to interstitial fibrosis and tubular atrophy with clusterin
#3465Method for removal of triglycerides in lipoproteins other than low-density lipoproteins
#3466METHODS AND KITS FOR DIAGNOSING HEPARIN-INDUCED THROMBOCYTOPENIA
#3467Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
#3468Biomarker for determining mitochondrial damage in friedreich's ataxia
#3469Soluble VEGFR-1 variants for diagnosis of preeclampsia
#3470Biomarker of depression, method for measuring biomarker of depression, computer program, and recording medium
#3471Blood biomarkers for necrotizing enterocolitis
#3472Ultra-small ApoB-containing particles and methods of use thereof
#3473METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF WOUNDS
#3474Novel ChREBP Isoforms and Methods Using the Same
#3475POLYPEPTIDE MARKERS FOR THE EARLY RECOGNITION OF THE REJECTION OF TRANSPLANTED KIDNEYS
#3476METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#3477Method for the in vitro prediction of the probability of a patient developing severe dengue, based on a blood sample
#3478Prognostic Biomarkers in Patients with Ovarian Cancer
#3479Method for predicting the response to HER2-directed therapy
#3480Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
#3481BIOMARKERS FOR THE DIAGNOSIS, PROGNOSIS, ASSESSMENT AND THERAPY STRATIFICATION OF SYNCOPE
#3482Method of diagnosing and treating infectious disseminated intravascular coagulation
#3483Biochemical markers for CVD risk assessment
#3484Anti-FcRn antibodies
#3485Method for Predicting the Risk of Getting a Cardiovascular Event in a Female Subject
#3486ENDOTHELIAL CELLS ACTIVATION BIOMARKERS CHARACTERIZING ANTIBODY MEDIATED REJECTION AND USES THEREOF
#3487COMPOSITIONS AND METHODS FOR TREATING CARDIAC HYPERTROPHY
#3488Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline
#3489Method for Identifying Agents Capable of Inducing Respiratory Sensitization and Array and Analytical Kits for Use in the Method
#3490Quantitative determination of biomarkers in the erythrocyte membrane
#3491BIOMARKERS FOR ADVERSE CARDIAC REMODELING
#3492CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF LOW ABUNDANT HUMAN PLASMA PROTEIN BIOMARKERS
#3493Method for evaluating ischemic heart disease by assaying complement factor H or D
#3494METHODS OR RISK ASSESSMENT OF PML AND RELATED APPARATUS
#3495SGLT2 AS BIOMARKER FOR DIAGNOSING CHRONIC KIDNEY DISEASE AND MONITORING THE DISEASE STATUS AFTER TREATMENT
#3496Detection and treatment of cancer
#3497Peptide inhibitors of calcium oxalate monohydrate crystallization and uses thereof
#3498PGLYRP2 biomarker in idiopathic pneumonia syndrome
#3499Anti-GP41 antibody-specific capture agents, compositions, and methods of using and making
#3500Prophylactic or therapeutic agent for hepatic diseases
#3501Method and system for detecting and differentiating cancer and sepsis in mammals using biomarkers
#3502Method for diagnosis of pulmonary involvement in systemic sclerosis
#3503METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3504METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF TISSUE OR ORGAN FIBROSIS IN A REPARATIVE OR REACTIVE PROCESS
#3505METHOD TO PREDICT THE PRESENCE OF INFLAMMATION OR ITACONIC ACID, IRG1 AND/OR PROTEIN IRG1 IN A SUBJECT AND PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATION
#3506Complement Pathway Inhibitors Binding To C5 And C5A Without Preventing The Formation Of C5B
#3507Anti-VEGF antibodies
#3508Predicting risk of major adverse cardiac events
#3509Compositions and methods related to protein displacement therapy for myotonic distrophy
#3510METHOD OF SUB-CLASSIFYING BREAST CANCER TUMORS
#3511Prognosis of adverse events in patients with suspected chronic heart failure
#3512Use of biomarkers in the assessment of the early transition from arterial hypertension to heart failure
#3513DNA sequence and preparation of grass pollen allergen Phl p 4 by recombinant methods
#3514Diagnostic tools for response to 6-thiopurine therapy
#3515MECHANISM, DIAGNOSTIC, AND TREATMENTS FOR COMPLICATIONS OF RENAL FAILURE
#3516S100A4 antibodies and therapeutic uses thereof
#3517Use of secretor, lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
#3518Methods to Assess Treatment Outcomes in Reward Deficiency Syndrome (RDS) Behaviors Utilizing Expression Profiling
#3519Phenylacetylglutamine as a biomarker for healthy aging
#3520Use of integrin beta subunits in the diagnosis of venous thromboembolism
#3521PC-O 40:1 as a biomarker for healthy aging
#35229-oxo-HODE as a biomarker for healthy aging
#3523Fractional C-reactive protein (fracCRP) antibodies and assays
#3524Methods For Regulating Hair Growth Disorders
#3525THERAPEUTIC TARGETS FOR MITOCHONDRIAL DISORDERS
#3526Method of assessing pancreatic beta-cell function
#3527METHODS OF ASSESSING SUSCEPTIBILITY TO DRUG-INDUCED THROMBOCYTOPENIA
#3528POLYPEPTIDE MARKERS FOR DIAGNOSIS AND ASSESSMENT OF HEART FAILURE
#3529Detection of platelet-derived shed CD31
#3530Device and method for detection of analytes
#3531Thermoelectric sensor for analytes in a gas and related method
#3532Process for determining the susceptibility to nosocomial infections
#3533Synthetic active peptide fragments
#3534Method and composition for treating acne
#3535COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST
#3536METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3537Reagents and methods for detecting a polymorphic protein
#3538Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject
#3539Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease
#3540Compositions for treatment of celiac disease
#3541Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome
#3542Diagnostic methods of eosinophilic esophagitis
#3543Endometrial phase or endometrial cancer biomarkers
#3544BIOMARKERS AND TEST PANELS USEFUL IN SYSTEMIC INFLAMMATORY CONDITIONS
#3545Nucleic acids encoding anti-Siglec-15 antibodies
#3546Methods for diagnosis and prognosis of renal injury and renal failure
#3547METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3548Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
#3549METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES
#3550Analytical tool and method for determining a condition of an oral cavity
#3551Anti-HLA monoclonal chimeric immunoglobulin, method and kit implementing such a monoclonal chimeric immunoglobulin
#3552Systemic genotoxicity as blood marker for allergic inflammation
#3553ARRDC1-mediated microvesicles (ARMMs) and uses thereof
#3554METHOD FOR IDENTIFYING A SUBJECT AT RISK OF DEVELOPING HEART FAILURE BY DETERMINING THE LEVEL OF GALECTIN-3 OR THROMBOSPONDIN-2
#3555ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
#3556Use of relaxin to treat placental syndromes
#3557METHOD FOR THE DETERMINATION OF RENAL FUNCTION
#3558ASSAY AND METHOD FOR DETERMINING INSULIN-RESISTANCE
#3559Method of predicting acute appendicitis
#3560Compositions and Methods of Detecting and Treating Neural Tube Defects
#3561KIDNEY FUNCTION BIOMARKERS
#3562Method of determination of risk of 2 hour blood glucose equal to or greater than 140 mg/dL
#3563Diagnostic chewing gum for pathogens
#3564POLYPEPTIDE MARKER FOR DIAGNOSING AND ASSESSING VASCULAR DISEASES
#3565MEANS AND METHODS FOR ASSESSING BONE DISORDERS
#3566Biomarkers for diagnosing ischemia
#3567Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress
#3568MEANS AND METHODS FOR ASSESSING LIVER DISORDERS
#3569Oligopeptidic compounds and uses thereof
#3570Fusion proteins and their use in the diagnosis and treatment of leishmaniasis
#3571Methods for diagnosis, prognosis and methods of treatment
#3572Device for the diagnosis of inflammatory tissues in dental applications
#3573Diagnosis and treatment for respiratory tract diseases
#3574MEANS AND METHODS FOR ASSESSING KIDNEY TOXICITY
#3575System for detecting infection in synovial fluid
#3576Diagnosis and risk stratification by determining the marker CT-proADM
#3577METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3578MEANS AND METHODS FOR ASSESSING AN ENDOCRINE DISEASE OR DISORDER
#3579P-cresol sulphate as a biomarker for healthy aging
#3580Immune-modifying nanoparticles for the treatment of inflammatory diseases
#3581Catalyst and process for preparing acrolein and/or acrylic acid by dehydration reaction of glycerin
#3582ADAM12 inhibitors and their use against inflammation-induced fibrosis
#3583METHODS FOR THE DETECTION AND THE TREATMENT OF DIASTOLIC DYSFUNCTION
#3584PEPTIDIC INHIBITOR OF SIGNAL TRANSMISSION FROM G-ALPHA-S TO G-ALPHA-I-COUPLED RECEPTOR CASCADES
#3585Biomarkers for insulin resistance and methods using the same
#3586BIOMARKERS
#3587PROTEIN BIOMARKERS OF LATE STAGE BREAST CANCER
#3588PROTEIN BIOMARKERS OF RECURRENT BREAST CANCER
#3589Biomarker for Barrett's Oesophagus
#3590BIOLOGICAL MARKER FOR EARLY CANCER DETECTION AND METHODS FOR CANCER DETECTION (BF819)
#3591MONOCYTE-DERIVED NUCLEIC ACIDS AND RELATED COMPOSITIONS AND METHODS
#3592Methods for treating vascular leak syndrome
#3593Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease
#3594Health test for a broad spectrum of health problems
#3595DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#3596Methods for diagnosis and prognosis of renal injury and renal failure using insulin-like growth factor-binding protein 7 and metalloproteinase inhibitor 2
#3597LAMIN A/C AND PRELAMINS AS INDICATORS OF FRAILTY AND VULNERABILITY OR RESILIENCY TO ADVERSE HEALTH OUTCOMES
#3598System and method for determining individualized medical intervention for a disease state
#3599METHODS AND REAGENTS FOR EVALUATING AUTOIMMUNE DISEASE AND DETERMINING ANTIBODY REPERTOIRE
#3600METHOD FOR DIGANOSING ATHEROSCLEROTIC PLAQUES BY MEASUREMENT OF CD36